262 related articles for article (PubMed ID: 26063760)
1. Regulation of a strong F9 cryptic 5'ss by intrinsic elements and by combination of tailored U1snRNAs with antisense oligonucleotides.
Balestra D; Barbon E; Scalet D; Cavallari N; Perrone D; Zanibellato S; Bernardi F; Pinotti M
Hum Mol Genet; 2015 Sep; 24(17):4809-16. PubMed ID: 26063760
[TBL] [Abstract][Full Text] [Related]
2. High-throughput analysis revealed mutations' diverging effects on
Souček P; Réblová K; Kramárek M; Radová L; Grymová T; Hujová P; Kováčová T; Lexa M; Grodecká L; Freiberger T
RNA Biol; 2019 Oct; 16(10):1364-1376. PubMed ID: 31213135
[TBL] [Abstract][Full Text] [Related]
3. An Altered Splicing Registry Explains the Differential ExSpeU1-Mediated Rescue of Splicing Mutations Causing Haemophilia A.
Balestra D; Maestri I; Branchini A; Ferrarese M; Bernardi F; Pinotti M
Front Genet; 2019; 10():974. PubMed ID: 31649737
[TBL] [Abstract][Full Text] [Related]
4. Disease-causing variants of the conserved +2T of 5' splice sites can be rescued by engineered U1snRNAs.
Scalet D; Maestri I; Branchini A; Bernardi F; Pinotti M; Balestra D
Hum Mutat; 2019 Jan; 40(1):48-52. PubMed ID: 30408273
[TBL] [Abstract][Full Text] [Related]
5. An exon-specific U1 small nuclear RNA (snRNA) strategy to correct splicing defects.
Fernandez Alanis E; Pinotti M; Dal Mas A; Balestra D; Cavallari N; Rogalska ME; Bernardi F; Pagani F
Hum Mol Genet; 2012 Jun; 21(11):2389-98. PubMed ID: 22362925
[TBL] [Abstract][Full Text] [Related]
6. Determinants of the inherent strength of human 5' splice sites.
Roca X; Sachidanandam R; Krainer AR
RNA; 2005 May; 11(5):683-98. PubMed ID: 15840817
[TBL] [Abstract][Full Text] [Related]
7. Negative and positive mRNA splicing elements act competitively to regulate human immunodeficiency virus type 1 vif gene expression.
Exline CM; Feng Z; Stoltzfus CM
J Virol; 2008 Apr; 82(8):3921-31. PubMed ID: 18272582
[TBL] [Abstract][Full Text] [Related]
8. Intrinsic differences between authentic and cryptic 5' splice sites.
Roca X; Sachidanandam R; Krainer AR
Nucleic Acids Res; 2003 Nov; 31(21):6321-33. PubMed ID: 14576320
[TBL] [Abstract][Full Text] [Related]
9. Modeling splicing outcome by combining 5'ss strength and splicing regulatory elements.
Müller L; Ptok J; Nisar A; Antemann J; Grothmann R; Hillebrand F; Brillen AL; Ritchie A; Theiss S; Schaal H
Nucleic Acids Res; 2022 Aug; 50(15):8834-8851. PubMed ID: 35947702
[TBL] [Abstract][Full Text] [Related]
10. How to Design U1 snRNA Molecules for Splicing Rescue.
Matos L; Santos JI; Coutinho MF; Alves S
Methods Mol Biol; 2022; 2434():89-102. PubMed ID: 35213011
[TBL] [Abstract][Full Text] [Related]
11. Compensatory signals associated with the activation of human GC 5' splice sites.
Kralovicova J; Hwang G; Asplund AC; Churbanov A; Smith CI; Vorechovsky I
Nucleic Acids Res; 2011 Sep; 39(16):7077-91. PubMed ID: 21609956
[TBL] [Abstract][Full Text] [Related]
12. Exploring Splicing-Switching Molecules For Seckel Syndrome Therapy.
Scalet D; Balestra D; Rohban S; Bovolenta M; Perrone D; Bernardi F; Campaner S; Pinotti M
Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):15-20. PubMed ID: 27639833
[TBL] [Abstract][Full Text] [Related]
13. Aberrant 5' splice sites in human disease genes: mutation pattern, nucleotide structure and comparison of computational tools that predict their utilization.
Buratti E; Chivers M; Královicová J; Romano M; Baralle M; Krainer AR; Vorechovsky I
Nucleic Acids Res; 2007; 35(13):4250-63. PubMed ID: 17576681
[TBL] [Abstract][Full Text] [Related]
14. Extensive in silico analysis of NF1 splicing defects uncovers determinants for splicing outcome upon 5' splice-site disruption.
Wimmer K; Roca X; Beiglböck H; Callens T; Etzler J; Rao AR; Krainer AR; Fonatsch C; Messiaen L
Hum Mutat; 2007 Jun; 28(6):599-612. PubMed ID: 17311297
[TBL] [Abstract][Full Text] [Related]
15. Splicing analysis of STAT3 tandem donor suggests non-canonical binding registers for U1 and U6 snRNAs.
Kramárek M; Souček P; Réblová K; Grodecká LK; Freiberger T
Nucleic Acids Res; 2024 Jun; 52(10):5959-5974. PubMed ID: 38426935
[TBL] [Abstract][Full Text] [Related]
16. Principles and correction of 5'-splice site selection.
Malard F; Mackereth CD; Campagne S
RNA Biol; 2022 Jan; 19(1):943-960. PubMed ID: 35866748
[TBL] [Abstract][Full Text] [Related]
17. Pick one, but be quick: 5' splice sites and the problems of too many choices.
Roca X; Krainer AR; Eperon IC
Genes Dev; 2013 Jan; 27(2):129-44. PubMed ID: 23348838
[TBL] [Abstract][Full Text] [Related]
18. RNA Secondary Structure-Based Design of Antisense Peptide Nucleic Acids for Modulating Disease-Associated Aberrant Tau Pre-mRNA Alternative Splicing.
Ong AAL; Tan J; Bhadra M; Dezanet C; Patil KM; Chong MS; Kierzek R; Decout JL; Roca X; Chen G
Molecules; 2019 Aug; 24(16):. PubMed ID: 31434312
[TBL] [Abstract][Full Text] [Related]
19. Ranking noncanonical 5' splice site usage by genome-wide RNA-seq analysis and splicing reporter assays.
Erkelenz S; Theiss S; Kaisers W; Ptok J; Walotka L; Müller L; Hillebrand F; Brillen AL; Sladek M; Schaal H
Genome Res; 2018 Dec; 28(12):1826-1840. PubMed ID: 30355602
[TBL] [Abstract][Full Text] [Related]
20. Binding of hnRNP H and U2AF65 to respective G-codes and a poly-uridine tract collaborate in the N50-5'ss selection of the REST N exon in H69 cells.
Ortuño-Pineda C; Galindo-Rosales JM; Calderón-Salinas JV; Villegas-Sepúlveda N; Saucedo-Cárdenas O; De Nova-Ocampo M; Valdés J
PLoS One; 2012; 7(7):e40315. PubMed ID: 22792276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
